NLRP3 and lobular neoplasia: Therefore, future work can contribute, providing a more detailed understanding of the regulatory mechanisms of the NLRP3 inflammasome in kidney cells of patients with LN, and clinical trials are needed to evaluate the effects of NLRP3 inflammasome inhibitors in preventing the progression of lupus kidney disease.